Abstract
Paclitaxel is an anticancer therapeutic produced by the yew tree. Over the last two decades, a significant bottleneck in the reconstitution of early paclitaxel biosynthesis has been the propensity of heterologously expressed pathway cytochromes P450, including taxadiene 5α-hydroxylase (T5αH), to form multiple products. Here, we structurally characterize four new products of T5αH, many of which appear to be over-oxidation of the primary mono-oxidized products. By tuning the promoter strength for T5αH expression in Nicotiana plants, we observe decreased levels of these proposed byproducts with a concomitant increase in the accumulation of taxadien-5α-ol, the paclitaxel precursor, by three-fold. This enables the reconstitution of a six step biosynthetic pathway, which we further show may function as a metabolic network. Our result demonstrates that six previously characterized Taxus genes can coordinatively produce key paclitaxel intermediates and serves as a crucial platform for the discovery of the remaining biosynthetic genes.
Similar content being viewed by others
Introduction
Paclitaxel is an FDA-approved anti-cancer drug (Taxol®) used to treat breast, ovarian, and lung cancer. The drug stabilizes microtubules and in turn blocks cell cycle progression 11,2. It was first discovered from the Pacific yew tree (Taxus brevifolia) through an anti-cancer screening program conducted by National Cancer Institute (NCI) in 19643. Paclitaxel belongs to a class of diterpenoids from Taxus called taxanes, of which more than 500 structures have been reported4. Despite the success of paclitaxel in clinical applications, its limited availability due to low natural abundance (~0.004% in Taxus bark2) has prompted extensive research into alternative and sustainable production methods, including semi-synthesis from late-stage intermediates and cultivation of plant-cell cultures5. Refactoring plant biosynthetic pathways into microorganisms is a promising way to produce medically valued plant natural products like paclitaxel, and successful examples include antimalarial drug artemisinin6 and anticholinergic drug scopolamine7. Nevertheless, the prerequisite for plant natural product production in microbial hosts is a complete understanding of the biosynthetic pathway. To date, despite extensive investigation over the past two decades, the full biosynthetic route to paclitaxel has not been elucidated.
Taxol biosynthesis is hypothesized to involve 19 Taxus enzymes, of which five are yet to be discovered (Fig. 1a, Supplementary Fig. 1)8. Elucidating the missing enzymes is hindered by the lack of access to intermediate substrates for functional characterization. The unknown biosynthetic enzymes are thought to act in the middle part of the pathway, as their substrates are notoriously difficult to obtain through synthesis or heterologous reconstitution (Supplementary Fig. 1). In the first committed step of paclitaxel biosynthesis, a diterpene cyclase taxadiene synthase (TS) converts geranyl geranyl pyrophosphate (GGPP) to taxadiene (1), which serves as the backbone of paclitaxel and related taxanes (Fig. 1a). Taxadiene 5α-hydroxylase (T5αH), a cytochrome P450 enzyme, is proposed to carry out the second step in the pathway, hydroxylating taxadiene (1) to yield taxadien-5α-ol (2) (Fig. 1a). However, the observed catalytic promiscuity of T5αH on heterologous expression has been a bottleneck in paclitaxel biosynthetic pathway reconstitution for nearly two decades. Expression of T5αH in different heterologous systems, such as Escherichia coli,9,10,11 Saccharomyces cerevisiae12,13 and Nicotiana benthamiana14 (Supplementary Table 1), results in multiple oxidized taxadiene products. While up to 12 products have been reported11, only three have been structurally characterized, namely, taxadien-5α-ol (2), rearranged products 5(12)-oxa-3(11)-cyclotaxane (OCT, 3)15 and 5(11)-oxa-3(11)-cyclotaxane (iso-OCT, 4)16. In these heterologous systems, taxadien-5α-ol (2) is often a minor product among all oxidized taxadienes2,10,11,12,13,14,15,17,18,19. Taxadien-5α-ol (2) is generally regarded as the precursor to paclitaxel as 2 and its acetate ester can be transformed by Taxus microsomes to yield poly-oxidized products20. Conversely, there is still uncertainty regarding the involvement of other oxidized taxadienes products in paclitaxel biosynthesis in Taxus. While it has been proposed that oxidized taxadienes are merely the breakdown products of a reactive epoxide intermediate generated by T5αH16,18,19, it has also been shown that oxidized taxadienes such as OCT (3) can be produced in Taxus plants when supplemented with a high level of taxadiene (1) and cannot be ruled out as paclitaxel precursors19.
The observed catalytic promiscuity of T5αH hinders the reconstitution of paclitaxel biosynthesis as it reduces the metabolic flux toward taxadien-5α-ol (2) and multiple oxidized products potentially complicate product deconvolution. Attempts to minimize undesired oxidized taxadiene formation in microbial hosts have included engineering of T5αH and its cytochrome P450 reductase (CPR) partner2,21 or through optimizing microbial growth conditions2,21. These approaches have failed to significantly increase the percentage of taxadien-5α-ol (2) among oxidized products, nor has permitted reconstitution of the biosynthesis by co-expressing the proposed downstream biosynthetic genes. Proposed downstream enzymes like taxadien-5α-ol O-acetyltransferase (TAT)22, taxane 10β-hydroxylase (T10βΗ)23, taxane 13α-hydroxylase (T13αΗ)24 and 10-deacetylbaccatin III:10-O-acetyltransferase (DBAT)25 have been individually characterized with purified substrates, but no reconstitution attempt has showed them all working in synchrony with TS and T5αΗ. To the best of our knowledge, the longest reconstitution efforts towards paclitaxel biosynthesis have been the co-expression of TS, T5αΗ, TAT and T10βΗ through yeast-E. Coli co-cultures17,26 and in N. benthamiana14, respectively. However, in these studies, the proposed final product was not observed or produced in minor quantities insufficient for structural characterization by nuclear magnetic resonance (NMR). In this work, we determine the structures of four previously uncharacterized oxidized taxadiene products from T5αΗ, whose structures suggested that T5αΗ further oxidize primary products like taxadien-5α-ol (2) and OCT (3). We also demonstrate that over-expressed T5αH can directly oxidize 2. Therefore, we propose overexpression of T5αΗ as one of the reasons for its observed catalytic promiscuity. By tuning the expression level of T5αH in N. benthamiana, we are able to increase the proportion of taxadien-5α-ol (2) among oxidized taxadienes and reduce the formation of confounding side-products. Using this optimized system, we reconstitute an early paclitaxel biosynthetic network with six characterized Taxus enzymes, where the final products are purified and structurally characterized by 2D-NMR. Accessing these early paclitaxel biosynthetic intermediates will enable future discovery of missing biosynthetic enzymes.
Results
Heterologous expression of T5αH with upstream pathway
To establish a baseline for taxadien-5α-ol (2) production prior work, we first transiently expressed T5αΗ in N. benthamiana via Agrobacterium-mediated transformation using the pEAQ-HT vector27, where genes are expressed under the strong, constitutive 35S promoter to maximize protein production. T5αH was co-expressed simultaneously with a previously established taxadiene-enhancing system through re-localizing TS to cytosol (cytoTS) and overexpressing cytosolic mevalonate pathway genes (tHMGR and GGPPS)28. At least 36 oxidized products were observed by gas chromatography mass spectrometry (GCMS) analysis of leaf extracts (Fig. 1b, Supplementary Fig. 2, Supplementary Table 2). All products are divided into two categories: “mono-oxidized taxadiene” and “poly-functionalized taxadiene” (Fig. 1b). Mono-oxidized taxadiene consists of products with a single oxidation identified based on their GCMS mass spectra. Poly-functionalized taxadiene includes mostly di- and tri-oxidized taxadienes indicated by their GCMS mass spectra, but also products with other modifications like ketone formation and hydrolysis (proposed based on GCMS mass spectra). All of these products are not unique to a plant host system: similarly, we observed 21 oxidized taxadienes when TS and T5αΗ were chromosomally integrated and co-expressed in S. cerevisiae (Supplementary Fig. 2)29. Among the oxidized products, only three have been thoroughly characterized – taxadien-5α-ol (2), OCT (3)15 and iso-OCT (4)16. We synthesized taxadien-5α-ol (2) standard via an allylic oxidation on taxadiene (1) (Fig. 2a)30, which can be easily purified from a TS-expressing yeast strain. With the standard, we confirmed taxadien-5α-ol (2) was heterologously produced in our N. benthamiana system as a minor product (Figs. 1b and 2b). The identity of OCT (3) was confirmed by NMR and mass spectrum (Supplementary Fig. 3) while the structural assignment of iso-OCT (4) was supported by its mass spectrum (Supplementary Fig. 3) and retention time earlier than 2 on GCMS (Fig. 1b) as previously reported11,16. Given the sheer number of uncharacterized products generated by T5αΗ in heterologous systems, it was unclear which compounds are true paclitaxel biosynthetic precursors, which are potentially involved in other non-paclitaxel biosynthetic pathways, and which are artifacts resulting from heterologous expression. Therefore, we set out to purify and structurally characterize oxidized taxadienes via large-scale infiltration of N. benthamiana plants and large-scale culturing of S. cerevisiae (Supplementary Table 3).
Characterization of T5αH product profile
Mono-oxidized 5, di-oxidized 6–7 (in acetylated form; result of co-expressing a TAT homolog, TAX19)31 and di-oxidized taxadiene 8, (Fig. 2c) were isolated and their structures were resolved through extensive 1D- and 2D-NMR analysis (Supplementary Tables 3–7). Structural assignment suggests that compound 5 contains a unique 6/7/6-membered ring scaffold and a 5,11-ether bond similar to the structure of iso-OCT. We proposed that the formation of this scaffold is the result of two Wagner-Meerwein rearrangements that form C-C bonds between C-11/15 and C-12/16 (Supplementary Fig. 4). Compound 6 has a 4,19-ether bond and a 5-hydroxyl group similar to 2. We found compound 7 to share the OCT (3) scaffold, but with an additional 9α-hydroxyl group. Our proposed structure of 8 has a 3,12-C-C linkage and 5,11-hydroxyl groups. We reasoned that 8 is a breakdown product of the 5,11-ether precursor [5(11)-oxa-3(12)-cyclotaxane], a hypothetical rearranged product produced alongside the formation of 3 and 4 (Supplementary Fig. 4). Notably, compounds 3–5 and 7–8 have distinct ether and/or C-C bonds in their structures that replace the usual C-11/12 double bond. Although we cannot rule out the possibility that these molecules represent true paclitaxel pathway intermediates, it seems unlikely given that the C-11/12 double bound is maintained in most taxanes isolated from Taxus plants4, and no enzymes have been identified to have the ability to re-install this desaturation. We therefore assumed that taxadien-5α-ol (2) is the main precursor for paclitaxel biosynthesis among all the oxidized taxadienes generated by T5αH in heterologous systems.
Poly-functionalized products, especially di- and tri-oxidized taxadienes, may arise from over-oxidation of mono-oxidized taxadienes by T5αH. This is supported by previous characterization of 10-hydroxy-OCT as one of T5αΗ’s minor products32 and our structural characterization of 6 and 7 in this study. To test this hypothesis, we fed synthetic 2 to N. benthamiana leaves expressing T5αH and observed complete turnover of 2 to 9 (Fig. 2d). Compound 9 is proposed to be a di-oxidized product based on its mass spectra (Supplementary Table 2) and it accumulates as a minor product in our T5αΗ-expressing N. benthamiana system (Fig. 1b). The formation of over-oxidized products like 9 not only diverts the flux away from 2 but also complicates pathway reconstitution: when the next biosynthetic gene TAT is co-expressed with TS and T5αH in N. benthamiana, we observed two new peaks 10 and 11 with simultaneous disappearance of 2 and 9 (Fig. 2e), suggesting that TAT is able to accept both 2 and 9 as substrates. Additional introduction of downstream biosynthetic enzymes would likely result in a complex product profile where on-pathway paclitaxel intermediates are only present as minor products, as observed in previous reconstitution attempts14,17,26. We speculated that over-oxidation is caused by the high levels of T5αΗ in the N. benthamiana over-expression system resulting in decoupled oxidation cycles and/or misfolded protein that retains undesirable activity. Given these results, we considered that lowering the production level of T5αH might mitigate over-oxidation and allow successful pathway reconstitution.
Tuning T5αH transcription levels alleviates over-oxidation
The combination of Agrobacterium and pEAQ vector has been a robust system to transiently express non-native biosynthetic genes in N. benthamiana for plant biosynthetic pathway discovery over the last decade27,33. In the pEAQ vector, genes are expressed under a strong constitutive 35S promoter to maximize protein production27,33. To lower the T5αH production level, we identified two weaker constitutive promoters – ubiquitin-10 (UBQ10) and nopaline synthase (NOS) promoter – that resulted in 75% and 63% of the expression level observed with the 35S promoter, respectively (as estimated by GFP fluorescence in N. benthamiana, Supplementary Fig. 5)34. We replaced the 35S promoter in pEAQ vector with either the UBQ10 or NOS promoter and tested T5αΗ activity in the new vectors when co-expressed with TS. Expression of T5αH under UBQ10 or NOS promoter greatly suppressed the formation of poly-functionalized taxadienes, and the highest taxadien-5α-ol (2) level was observed in the NOS system (Fig. 3a). Notably, taxadiene (1) was depleted in all three expression systems (Supplementary Fig. 6), suggesting that lower expression of T5αH does not comprise its utilization of 1. By integrating the peak area of each oxidized product on the total ion chromatogram (TIC) and dividing by total integration area, we calculated the percentage for each product (Fig. 3b, Supplementary Fig. 6, Source Data) as an approximation of the product distribution (assuming all products have similar ionization efficiencies). The percentage of poly-functionalized products decreased significantly from 68% to 37% and 25% with UBQ10 or NOS promoters, respectively. Furthermore, synthetic 2 was no longer completely oxidized to 9 when fed into N. benthamiana leaves expressing (NOS)T5αH in contrast to (35S)T5αH (Supplementary Fig. 7), supporting our hypothesis that T5αH over-oxidation is due to its high expression level.
While the weaker promoters decreased the abundance of poly-functionalized products, the ratio between the four major mono-oxidized taxadienes (2/3/4/5) remained largely the same (Fig. 3c). Thus, mono-oxidized taxadienes like 3–5 may be formed due to incompatibility of T5αH with its microenvironment in heterologous systems compared to native plants. This phenomenon has been shown with other P450s where their activities are highly dependent on the membrane phospholipid composition35 and the availability of native partner proteins (e.g., metabolon formation)36. With a more favorable microenvironment that mimics the native condition, it is possible that T5αH would generate 2 as the major mono-oxidized product. Future work to resolve the heterologous expression incompatibility is needed to increase the overall percentage of taxadien-5α-ol (2).
By tuning the expression level of T5αΗ, we achieved: (1) three-fold increase in the absolute level of taxadien-5α-ol (2) per leaf dried weight using the NOS promoter (Fig. 3a, c and Source Data), and (2) reduced formation of side-products, including poly-functionalized products and mono-oxidized products other than 2–5 (Fig. 3a, b), which minimizes potential confounding interactions with downstream biosynthetic enzymes. We next proceeded to reconstitute the early paclitaxel biosynthetic pathway using the engineered NOS promoter system.
Reconstitution of early six-step paclitaxel biosynthetic pathway
Several Taxus enzymes proposed to be involved in early paclitaxel biosynthesis have been characterized, including cytochrome P450s T10βH23 and T13αH24 as well as acyltransferases TAT22 and DBAT25. We attempted to reconstitute the early paclitaxel biosynthetic pathway by transiently co-expressing these genes in N. benthamiana. To thwart the potential over-oxidation by Taxus cytochrome P450s under 35S promoter, all Taxus P450s were expressed under the NOS promoter. When TAT was introduced to the engineered TS + (NOS)T5αΗ system, we observed the formation of 5α-acetoxytaxadiene (11) (Fig. 4) as the sole dominant product. In contrast to when TAT was introduced to the previous strongly expressed TS + (35S)T5αH system, compound 10, the proposed acetylated product of 9, was no longer formed as a side-product (Fig. 2e, Supplementary Fig. 8), demonstrating the success of the lower-expression system (Fig. 4). T10βH has been shown to efficiently oxidize 5α-acetoxytaxadiene (11) to 5α-acetoxytaxadien-10β-ol (12) when expressed in yeast23, so we chose to introduce T10βH as the next enzyme for pathway reconstitution. When T10βΗ was introduced, a single new peak was observed coinciding with the disappearance of 11 (Fig. 4); we proposed this new product to be 5α-acetoxytaxadien-10β-ol (12) based on fragments of its mass spectrum (Supplementary Table 2). DBAT is an acyltransferase that acetylates 10-deacetylbaccatin III to baccatin III25, and it has also been shown that purified T. chinensis DBAT is highly regio selective for C-10β O-acetylation on various partially deacetylated taxuyuannanine C (taxadien-2α,5α,10β-triacetoxy-14β-ol) substrates37. Given the high regio-selectivity of DBAT on less oxidized taxanes, we hypothesized that 12 can be transformed by DBAT if 12 indeed contains the 10β-hydroxyl group. The introduction of DBAT yielded a new peak with simultaneous disappearance of 12 (Fig. 4). Based on the mass spectrum of the new peak (Supplementary Table 2), we proposed this compound to be 5α,10β-diacetoxytaxadiene (13).
The early paclitaxel biosynthetic pathway is proposed to bifurcate from taxadien-5α-ol (2) by the action of TAT and T13αH (Supplementary Fig. 1)24. We decided to test T13αH together with all the enzymes (TS, T5αΗ, ΤΑΤ, T10βH, and DBAT) to see if new products can be formed. We again saw the formation of a new product 14 and concurrent reduction in the amount of 13 (Fig. 4). Based on its MS spectrum, 14 was tentatively assigned as 5α,10β-diacetoxytaxadien-13α-ol (14) (Supplementary Table 2). While we initially used GCMS to detect hydrophobic molecules including 2–13, as the taxadiene scaffold is decorated with more oxidations/acetylations and becomes more polar, we considered that untargeted liquid chromatography mass spectrometry (LCMS) may be more suitable for analysis. LCMS analysis of N. benthamiana extracts from leaves where all enzymes up to T13αΗ were expressed revealed 2 dominant products, one with the expected mass of 14 ([M+Na]+ = 427.2460) while the other one (15) has an additional degree of unsaturation ([M+Na]+ = 425.2304) (Fig. 4, Supplementary Fig. 9). To characterize the structures of 14 and 15, large-scale infiltration and purification were carried out to yield 14 and 15 in 63 ug/g dry weight (DW) and 42 ug/g DW yield, respectively. Extensive 1D- and 2D-NMR elucidated their structures as 5α,10β-diacetoxytaxadien-13α-ol (14) and 5α,10β-diacetoxytaxadien-13α-one (15) (Supplementary Table 8). When 14 was fed into control N. benthamiana expressing GFP, it was partially oxidized to 15 (Supplementary Fig. 10). Therefore, we concluded that 15 results from oxidation by endogenous N. benthamiana enzymes rather than oxidation by T13αH (Fig. 4). The production and structural characterization of 14 in N. benthamiana provides the evidence for the first time that six Taxus biosynthetic enzymes (TS, T5αH, TAT, T10βH, DBAT, and T13αΗ) are working in synchrony to produce early paclitaxel intermediates.
Metabolic network of early paclitaxel biosynthetic pathway
While we observed complete disappearance and appearance of what are proposed to be the substrate/product pairs with sequential introduction of biosynthetic enzymes from T5αH, TAT… to T13αH and illustrated the pathway as a linear series of steps (Fig. 4), it remains unclear in what order each enzyme acts. For example, it is possible that T13αH acts earlier in the pathway on 2 as previously reported24 instead of directly oxidizing 13 to form 14. To gain insight into the substrate preferences for these enzymes and further understand the reaction order of the pathway, we fed purified taxadien-5α-ol (2) into N. benthamiana leaves expressing different combinations of TAT, (NOS)T10βH, DBAT, and (NOS)T13αH. As expected, 2 can be efficiently transformed into 11–15 with sequential addition of TAT, T10βH, DBAT and T13αH (Fig. 5 exp.#1, 2, 6, 7 and 9), demonstrating that the new peaks accumulating in pathway reconstitution experiments (Fig. 4) indeed originate from 2. Furthermore, we showed that 2 can be a direct substrate for either TAT or T13αΗ, but not T10βH (Fig. 5 exp.#1-4), which is consistent with previously proposed actions of TAT and T13αΗ that lead to early bifurcation in the pathway20,24. The oxidation of 2 by T13αΗ results in a product whose mass corresponds to taxadien-5α,13α-diol (16) (Fig. 5 exp.#4), and, similarly, masses for 5α-acetoxytaxadien-13α-ol (18) and 5α-acetoxytaxadien-10β,13α-diol (20) were observed in T13αΗ + TAT and T13αΗ + TAT + T10βH combination, respectively (Fig. 5 exp.#5 and 8). Products with masses corresponding to C-13 ketone 5α-hydroxytaxadien-13-one (17), 5α-acetoxytaxadien-13-one (19), and 5α-acetoxy-10β-hydroxytaxadien-13-one (21) were also found in T13αΗ, T13αΗ + TAT and T13αΗ + TAT + T10βH combination, respectively (Fig. 5 exp.#4, 5 and 8). These C-13 ketone products likely result from N. benthamiana endogenous oxidation similar to the formation of 15 (Fig. 5, Supplementary Fig. 10).
When tested with purified substrates, it has been shown that recombinant T13αΗ oxidizes taxadien-5α-ol (2) efficiently, oxidizes 5α-acetoxytaxadiene (11) at 6% the conversion rate levels relative to 2, and has no activity on 5α-acetoxytaxadien-10β-ol (12)24. Therefore, the formations of 18 and 20 likely go through 16 instead of direct oxidation by T13αH on 11 and 12, respectively, as suggested in Fig. 5 scheme. Whether 13 is a direct substrate for T13αH to make 14 awaits further study. Compound 5α-acetoxytaxadien-10β-ol (12) and taxadien-5α,13α-diol (16) have been suggested as relevant biosynthetic intermediates in early paclitaxel biosynthesis as purified Taxus microsome produced 12 and 16 from exogenously supplied 11 and 2, respectively20. Detection of intermediates downstream of 12 and 16 (13, 14, 18 and 20) supports a converging metabolic network with 14 as the final product, which unites the two pathway branches previously proposed at a common intermediate20.
Discussion
To increase production of the desired product in heterologous hosts, metabolic engineering often employs the strategy of overexpressing the biosynthetic genes or upstream precursor pathways38,39. However, over-expression of membrane-bound P450s in heterologous hosts often leads to problems such as decreased P450s solubility and imbalance in electron transfer40,41,42. Previous engineering efforts on T5αH has mostly focused on solving these issues by optimizing N-terminal sequence and CPR ratio9,21. Here, we show that overexpression of T5αΗ results in over-oxidation of the desired product (regardless of the heterologous host) while lowering the expression level of T5αΗ using NOS promoter proves to be beneficial for the reconstitution of the paclitaxel biosynthesis. By avoiding the compounding formation of multiple side-products, this strategy helps to streamline the biosynthesis of productive intermediates.
While we have successfully alleviated T5αΗ over-oxidation using engineered NOS promoter system, undesired mono-oxidized taxadienes like OCT (3), iso-OCT (4) and 5 still account for more than 65% of the accumulated taxanes (Source Data). Their relative ratios remain similar when switching promoters (Fig. 3c) and their accumulations persist with the introduction of downstream enzymes (Fig. 4). Notably, 3–5 or molecules with related structures have not been shown to accumulate in native Taxus species, suggesting 3–5 are artifacts of heterologous pathway reconstitution4. We proposed that these mono-oxidized taxadienes result from unfavorable conditions for T5αΗ in heterologous expression systems and/or missing Taxus partner proteins that would enable proper enzymatic function through metabolon formation36. Yet another possibility is that partial reconstitution of biosynthetic pathways results in accumulation of shunt products derived from unstable intermediates, which has been observed for the reconstitution of bacterial polyketide pathways43. In addition to the set of biosynthetic enzymes used for the reconstitution here, enzymes that directly reduce the production of mono-oxidized taxadienes might be required. Future efforts on the discovery of missing partner proteins and biosynthetic enzymes would help alleviate the observed catalytic promiscuity of T5αH. Furthermore, engineering of the heterologous expression system and T5αH may further enhance taxadien-5α-ol (2) production42. For example, addition of a cytochrome b5 and lowering CPR expression ratio has shown to be critical for the optimal activity of CYP71AV1 in yeast for the production of artemisinin44, and co-expression of heme biosynthetic genes can mitigate the heme-depletion stress posed by overexpression of P450s in yeast45. Our structural characterization of 5 and proposed mechanisms for the formation of mono-oxidized taxadienes 3–5 (Supplementary Fig. 4) could also serve as useful resources for rational protein engineering of T5αH to increase selectivity toward the production of 210.
Distant phylogenetic relationships between native and heterologous hosts (in our case, Taxus, a gymnosperm, and Nicotiana, an angiosperm, plant) might cause issues in heterologous expression. Very few biosynthetic pathways from gymnosperm plants have been studied, and most involve many gymnosperm-specific P450s that are not well-characterized46, for example, the biosynthesis of ginkgolide from Ginkgo46,47. Improper post-translational modifications could happen to heterologously expressed proteins in phylogenetically distant species, as demonstrated by the incorrect glycosylation of a plant P450 SalSyn when heterologously expressed in yeast48. In the future, an engineered heterologous system optimized for the expression of gymnosperm P450s will accelerate the study of biosynthesis in these ancient plants.
More than 500 structurally different taxanes have been isolated from Taxus, where combinations of different tailoring modifications (e.g., oxidation and acetylation) on the taxadiene scaffold have been reported4. The metabolic network we proposed here could potentially explain how such huge structural diversity arises from a handful of biosynthetic enzymes. Similarly, metabolic networks have been reported for the biosynthesis of many plant terpenoids, including Arabidopsis root triterpenoids49, limonoids from Citrus and Melia50, and cyclic AMP booster forskolin51. Together, these discoveries support the perspective that terpenoid specialized metabolism in plant is generally composed of inter-connected metabolic networks instead of linear pathways52.
In summary, we have structurally characterized four oxidized taxadiene products from T5αΗ and confirmed overexpression as one of the mechanisms for undesired product formation. By using the lower-expression NOS promoter, we relieve the over-oxidation issue and increase the accumulation of taxadien-5α-ol (2) by three-fold. This allows successful reconstitution of an early paclitaxel biosynthetic network in a heterologous host involving TS, T5αH, TAT, T10βH, DBAT, and T13αΗ, concatenating the activities of these enzymes since their discoveries in the early 2000s. Our reconstitution effort of a relatively cleaner route to yield an isolatable level of 5α,10β-diacetoxytaxadien-13α-ol (14) will serve as a crucial platform for the discovery of downstream enzymes, including many of the P450s missing in the paclitaxel biosynthesis (Supplementary Fig. 1)53.
Methods
Cloning of biosynthetic genes
The cloning of cytosolic diterpenoid boost, tHMGR and GGPPS, and cytosolic TS are described in previous study28. Taxus TS1, TS2, T5αH, TAT, T10βΗ, DBAT, T13αΗ, and TAX19 genes (Supplementary Table 9) were synthesized by Gen9 Bio (San Jose, CA) and amplified by PCR using Q5 High-Fidelity DNA Polymerase (New England BioLabs) and gene-specific primers from Integrated DNA Technologies (Supplementary Table 10). PCR amplicons were ligated with AgeI- and XhoI- (New England BioLabs) linearized pEAQ-HT vector27 using HiFi DNA assembly mix (New England BioLabs). Constructs were transformed into 10-beta competent E. coli cells (New England BioLabs). Plasmid DNA was isolated using the QIAprep Spin Miniprep Kit (Qiagen) and sequence verified by Elim Biopharm.
Transient expression of Taxus genes in N. benthamiana via Agrobacterium-mediated infiltration
pEAQ-HT plasmids containing the Taxus gene were transformed into Agrobacterium tumefaciens (strain GV3101) cells using the freeze-thaw method. Transformed cells were grown on LB-agar plates containing kanamycin and gentamicin (50 and 30 μg/mL, respectively; same for the LB media below), at 30 °C for 2 days. Single colonies were then picked and grew overnight at 30 °C in LB-Kan/Gen liquid media. The overnight cultures were used to make DMSO stocks (7% DMSO) for long-term storage in the −80 °C fridge. For routine N. benthamiana infiltration experiments, individual Agrobacterium DMSO stocks were streaked out on LB-agar containing kanamycin and gentamicin and grew for 2 days at 30 °C. Patches of cells were scraped off from individual plates using 10 μL inoculation loops and resuspended in 1 mL of Agrobacterium induction buffer (10 mM MES pH 5.6, 10 mM MgCl2 and 150 μm acetosyringone; Acros Organics) in individual 2 mL safe-lock tubes (Eppendorf). The suspensions were briefly vortexed to homogeneity and incubated at room temperature for 2 h. OD600 of the individual Agrobacterium suspensions were measured, and the final infiltration solution where OD600 = 0.2 for each strain was prepared by mixing individual strains and diluting with the induction buffer. Leaves of 4-weeks old N. benthamiana were infiltrated using needleless 1 mL syringes from the abaxial side. Leaf-6, 7, and 8 (numbered by counting from the bottom) of N. benthamiana were used, and each experiment was tested on different plants and leaves as three biological replicates (for example, experiment 1 is tested on plant-1 leaf-6, plant-2 leaf-7, and plant-3 leaf-8).
Metabolite extraction of N. benthamiana leaves
N. benthamiana leaf tissue 5-days post Agrobacterium infiltration was collected using a leaf disc cutter 1 cm in diameter and placed inside a 2 mL safe-lock tube (Eppendorf). Each biological replicate consisted of 4 leaf discs from the same leaf (approximately 40 mg fresh weight). The leaf discs were flash-frozen and lyophilized overnight. To extract metabolites, ethyl acetate (ACS reagent grade; J.T. Baker) 500 μL was added to each sample along with one 5 mm stainless steel bead. The samples were homogenized in a ball mill (Retsch MM 400) at 25 Hz for 2 min. After homogenization, the samples were centrifuged at 18,200 × g for 10 min. For GCMS samples, the supernatants were filtered using hydrophobic PTFE filters with 0.45 μm pore size (Millipore) and transferred to 50 μL glass inserts placed in 2 mL vials. For LCMS samples, 100 μL of supernatants were transferred to a new microcentrifuge tube and evaporated to dryness under N2. The samples were reconstituted in 100 μL of acetonitrile (HPLC grade; Fischer Chemical), filtered using hydrophilic PTFE filters with 0.45 μm pore size (Millipore) and transferred to LCMS vials.
Large-scale fermentation of yeast culture
Starter yeast cultures (TS- or TS + T5αH-expressing; Supplementary Table 11) were grown in 3 mL of YPD media (10 g/L yeast extract, 20 g/L peptone, dextrose 40 g/L) in several 15 mL tubes overnight at 30 °C. The overnight cultures were used to inoculate (1:100 ratio) a total of 1–2 L of YPD media divided into multiple 500 mL or 1 L flasks where the liquid volume didn’t exceed 20% of the flask volume. The inoculated cultures were grown for 2 days at 30 °C to saturation. The saturated cultures were centrifuged at 2700 × g for 10 min and the resulting pellet was resuspended in YPG media (10 g/L yeast extract, 20 g/L peptone, galactose 40 g/L) to induce the expression of TS. The induced cultures were grown at 20 °C for 72 h with additional 10% (V:V) galactose (40% in water) supplemented at 24 and 48 h. The induced cultures were combined for the purification of taxadiene (TS-expressing) or mono-oxidized taxadienes (TS + T5αH-expressing).
Purification of taxadiene (1) from large-scale yeast culture
Equal volume of ethyl acetate (ACS reagent grade; J.T. Baker) and approximate 10 g of 0.5 mm glass beads (BioSpec) were added to 400 mL of induced TS-expressing yeast culture in a 2 L flask. The flask was shaken at 20 °C overnight. The culture was centrifuged at 2700 × g for 10 min. The pellet was discarded, and the supernatant (organic and aqueous layers) was extracted with 400 mL of ethyl acetate twice in a 2 L separatory funnel. Additional centrifugation of the supernatant might be helpful for the separation of the two phases. Organic phases were combined and dried using rotary evaporation. Flash chromatography was carried out using a 7 cm diameter column loaded with 20 g of P60 silica gel (SiliCycle) with hexane (HPLC grade; VWR) as the mobile phase. Isocratic elution (100% hexane) was performed and eluent was collected in 5 mL fractions. Fractions were analyzed by GCMS and those containing taxadiene were combined and dried by rotary evaporation to yield 15.5 mg of taxadiene (1) as colorless oil (39 mg/L). Iso-taxadiene was co-purified with 1 in a 1:10 ratio as indicated by NMR peak integration. The 1H and 13C NMR data of taxadiene (1) are reported in Supplementary Figs. 11–13.
Synthesis of taxadien-5α-ol (2)
The synthesis of taxadien-5α-ol (2) is adapted from a previously described method30. Tert-BuOOH (21.3 μL of 98% purity, 0.114 mmol; Sigma–Aldrich) was added to a solution of SeO2 (3.3 mg, 0.030 mmol; Strem) in CH2Cl2 (50 μL; Sigma–Aldrich) and stirred for 0.5 h. Subsequently, purified taxadiene (1) (15.5 mg, 0.0570 mmol) in CH2Cl2 (200 μL) was added to the solution and allowed to stir for 2.5 h at room temperature. The resulting yellow solution was concentrated on a rotary evaporator under reduced pressure to yield yellow crude oil. Flash chromatography was carried out using a 2 mL glass Pasteur pipette loaded with 200 mg of P60 silica gel (SiliCycle) with hexane (HPLC grade; VWR) as the initial mobile phase. The column was first eluded with 100% hexane to yield unreacted 1 (21% recovery), then with hexane-diethyl ether (Fischer Chemical) in a ratio of 5:1 to yield 2.3 mg of an over-oxidized ketone product (TLC Rf = 0.63 when eluded with hexane-Et2O 5:1 and stained with KMnO4; 14% isolated yield) and 1.8 mg of 2 (TLC Rf = 0.36 when eluded with hexane-Et2O 5:1 and stained with KMnO4; 11% isolated yield). Fractions were collected in 200 μL volume. The 1H NMR data of synthetic taxadien-5α-ol (2) are reported and compared to 2 heterologously produced in E. coli to confirm its identity (Supplementary Figs. 14–15).
Feeding taxadien-5α-ol (2) to N. benthamiana transiently expressing Taxus genes
Taxus genes were expressed using the Agrobacterium-mediated infiltration method described above. At 3-days post Agrobacterium infiltration, a 10 mM stock solution Taxadiene 5α-ol (2) in DMSO was diluted 100-fold with water to prepare 100 μm 2 solutions and infiltrated into N. benthamiana leaves expressing Taxus genes. Approximate 150 μL of the 100 μm 2 solutions was used per leaf to yield a circle with a diameter around 3 cm, which was marked for reference. After 18–24 h, the leaves were harvested by cutting along the marked area with a scissor and lyophilized overnight in pre-weighed 2 mL safe-lock tubes (Eppendorf). GCMS and LCMS samples were prepared following the aforementioned methods, with the exception of using ethyl acetate at a ratio of 20 μL per mg of dried-weight material.
GCMS analysis
GCMS samples were analyzed using an Agilent 7820 A gas chromatography system coupled to an Agilent 5977B single quadrupole mass spectrometer. Data were collected with Agilent Enhanced MassHunter and analyzed by MassHunter Qualitative Analysis B.07.00. Separation was carried out using an Agilent VF-5HT column (30 m × 0.25 mm × 0.1 μm) with a constant flow rate of 1 ml/min of helium. The inlet was set at 280 °C in split mode with a 10:1 split ratio. The injection volume was 1 μl. Oven conditions were as follows: start and hold at 130 °C for 2 min, ramp to 250 °C at 8 °C/min, ramp to 310 °C at 10 °C/min and hold at 310 °C for 5 min. Post-run condition was set to 320 °C for 3 min. MS data were collected with a mass range 50–550 m/z and a scan speed of 1562 u/s after a 4-min solvent delay. The MSD transfer line was set to 250 °C, the MS source was set to 230 °C and the MS Quad was set to 150 °C. The mass spectra of all compounds are reported in Supplementary Table 2.
LCMS analysis
LCMS samples were analyzed using an Agilent 1260 HPLC system coupled to an Agilent 6520 Q-TOF mass spectrometer. Data were collected with Agilent MassHunter Workstation Data Acquisition and analyzed by MassHunter Qualitative Analysis 10.0. Separation was carried out using a Gemini 5 μm NX-C18 110 Å column (2 × 100 mm; Phenomenex) with a mixture of 0.1% formic acid in water (A) and 0.1% formic acid in acetonitrile (B) at a constant flow rate of 400 μL/min at room temperature. The injection volume was 2 μl. The following gradient of solvent B was used: 3% 0–1 min, 3%–50% 1–2 min, 50%–97% 2–12 min, 97% 12–14 min, 97%–3% 14–14.5 min and 3% 14.5–21 min. MS data were collected using electrospray ionization (ESI) on positive mode with a mass range 50–1200 m/z and a rate of 1 spectrum/s. The ESI source was set as follows: 325 °C gas temperature, 10 L/min drying gas, 35 psi nebulizer, 3500 V VCap, 150 V fragmentor, 65 V skimmer, and 750 V octupole 1 RF Vpp. The mass spectra of all compounds are reported in Supplementary Table 2.
Large-scale infiltration of N. benthamiana
For large-scale infiltration, infiltration solution containing Agrobacterium (OD600 = 0.6 per strain) was prepared as described above with the following modifications: each Agrobacterium strain was grown in 1 L of LB-Kan/Gen for 2 days to saturation and harvested by centrifugation at 2700 × g for 10 min. Typically, 30–60 N. benthamiana (5–6 weeks old) were used in one experiment. Whole plants were submerged in 1.5 L infiltration solution and infiltrated under vacuum for at least 2 min. After 6–8 days post infiltration, leaves from infiltrated N. benthamiana were chopped into small pieces and lyophilized for 2–3 days.
Extraction and purification of taxanes from N. benthamiana and yeast
Compounds 3, 5, acetylated 6, acetylated 7, 14, and 15 were isolated from large-scale infiltration of N. benthamiana. Compound 1 and 8 were isolated from large-scale fermentation of yeast. Combinations of biosynthetic genes, scale (number of plants or volume of yeast culture) and yield are summarized in Supplementary Table 3. Dried N. benthamiana materials were extracted with 2 L ethyl acetate (ACS reagent grade; J.T. Baker) in a 4 L flask for 48 h at room temperature with constant stirring. Extracts were filtered using vacuum filtration and dried using rotary evaporation. TS + T5αH-expressing yeast culture (4*1 L) were directly extracted with 500 mL ethyl acetate (ACS reagent grade; J.T. Baker) in 2 L flasks with the addition of 0.5 mm glass beads (BioSpec) and shaken 20 °C overnight. The culture was centrifuged at 2700 × g for 10 min. The pellet was discarded, and the supernatant (organic and aqueous layers) was extracted with an equal volume of ethyl acetate twice in a 2 L separatory funnel. Additional centrifugation of the supernatant might be helpful for the separation of the two phases. Organic phases were combined and dried using rotary evaporation.
Two rounds of chromatography were used to isolate compounds of interest from the extracts of N. benthamiana and yeast. Chromatography conditions for each compound are summarized in Supplementary Table 3. In short, the first chromatography was performed using a 7-cm-diameter column loaded with P60 silica gel (SiliCycle) and using hexane (HPLC grade; VWR) and ethyl acetate as the mobile phases. The second chromatography was carried out on an automated Biotage Selekt system with a Biotage Sfar C18 Duo 6 g column using Milli-Q water and acetonitrile as the mobile phases. Fractions were analyzed by GCMS or LCMS to identify those containing the compound of interest. Desired fractions were pooled and dried using rotary evaporation (first round) or lyophilization (second round). Purified products were analyzed by NMR.
NMR analysis of purified compound
CDCl3 (Acros Organics) was used as the solvent for all NMR samples unless otherwise specified. 1H, 13C, and 2D-NMR spectra were acquired using either a Varian Inova 500 MHz or 600 MHz spectrometer at room temperature using VNMRJ 4.2, and the data were processed and visualized on MestReNova v14.3.1. Chemical shifts were reported in ppm downfield from Me4Si by using the residual solvent (CDCl3) peak as an internal standard (7.26 ppm for 1H and 77.16 ppm for 13C chemical shift). Spectra were analyzed and processed using MestReNova version 14.3.1-31739. The NMR data for compounds 1, 2, 3, 5, acetylated 6, acetylated 7, 8, 14, and 15 are provided in Supplementary Figs. 11–54 and the 1H/13C assignments for 5, acetylated 6, acetylated 7, 8, 14, and 15 are shown in Supplementary Tables 4–8.
Reporting summary
Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.
Data availability
The raw NMR free induction decay (FID) data of individual compounds have been deposited in the Natural Products Magnetic Resonance Database (np-mrd.org) with the following ID: 1 (NP0332339), 2 (NP0332341), 3 (NP0332444), 5 (NP0332420), acetylated 6 (NP0332441), acetylated 7 (NP0332421), 8 (NP0332442), 14 (NP0332342) and 15 (NP0332340); the processed NMR data are available in Supplementary Figs. 11–54 and Supplementary Tables 4–8. The integrated peak areas of individual compounds under the three promoters used for the plotting of Fig. 3 are provided in Source Data. Sequences of the biosynthetic enzymes used in this study are derived from GenBank with the following accession numbers: taxadiene synthase (U48796 and AY364470), T5αΗ (AY289209), TAT(AF190130), Τ10βΗ (AF318211), DBAT (AF456342), T13αΗ (AY056019), which are also listed in Supplementary Table 9. Source data are provided with this paper.
References
Gallego-Jara, J., Lozano-Terol, G., Sola-Martínez, R. A., Cánovas-Díaz, M. & de Diego Puente, T. A compressive review about Taxol®: history and future challenges. Molecules 25, 5986 (2020).
Wani, M. C. & Horwitz, S. B. Nature as a remarkable chemist: a personal story of the discovery and development of Taxol. Anticancer Drugs 25, 482–487 (2014).
Wall, M. E. & Wani, M. C. Camptothecin and taxol: from discovery to clinic. J. Ethnopharmacol. 51, 239–253 (1996). discussion 253–4.
Wang, Y.-F. et al. Natural taxanes: developments since 1828. Chem. Rev. 111, 7652–7709 (2011).
Liu, W. C., Gong, T. & Zhu, P. Advances in exploring alternative Taxol sources. RSC Adv. 6, 48800–48809 (2016).
Ro, D.-K. et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 440, 940–943 (2006).
Srinivasan, P. & Smolke, C. D. Biosynthesis of medicinal tropane alkaloids in yeast. Nature 585, 614–619 (2020).
Mutanda, I., Li, J., Xu, F. & Wang, Y. Recent advances in metabolic engineering, protein engineering, and transcriptome-guided insights toward synthetic production of Taxol. Front. Bioeng. Biotechnol. 9, 632269 (2021).
Ajikumar, P. K. et al. Isoprenoid pathway optimization for Taxol precursor overproduction in Escherichia coli. Science 330, 70–74 (2010).
Yadav, V. G. Unraveling the multispecificity and catalytic promiscuity of taxadiene monooxygenase. J. Mol. Catal. B Enzym. 110, 154–164 (2014).
Sagwan-Barkdoll, L. & Anterola, A. M. Taxadiene-5α-ol is a minor product of CYP725A4 when expressed in Escherichia coli. Biotechnol. Appl. Biochem. 65, 294–305 (2018).
Nowrouzi, B., Lungang, L. & Rios-Solis, L. Exploring optimal Taxol® CYP725A4 activity in Saccharomyces cerevisiae. Microb. Cell Fact. 21, 197 (2022).
Walls, L. E. et al. Optimizing the biosynthesis of oxygenated and acetylated Taxol precursors in Saccharomyces cerevisiae using advanced bioprocessing strategies. Biotechnol. Bioeng. 118, 279–293 (2021).
Li, J. et al. Chloroplastic metabolic engineering coupled with isoprenoid pool enhancement for committed taxanes biosynthesis in Nicotiana benthamiana. Nat. Commun. 10, 4850 (2019).
Rontein, D. et al. CYP725A4 from yew catalyzes complex structural rearrangement of taxa-4 (5), 11 (12)-diene into the cyclic ether 5 (12)-oxa-3 (11)-cyclotaxane. J. Biol. Chem. 283, 6067–6075 (2008).
Barton, N. A. et al. Accessing low-oxidation state taxanes: is taxadiene-4(5)-epoxide on the taxol biosynthetic pathway? Chem. Sci. 7, 3102–3107 (2016).
Zhou, K., Qiao, K., Edgar, S. & Stephanopoulos, G. Distributing a metabolic pathway among a microbial consortium enhances production of natural products. Nat. Biotechnol. 33, 377–383 (2015).
Biggs, B. W. et al. Orthogonal assays clarify the oxidative biochemistry of taxol P450 CYP725A4. ACS Chem. Biol. 11, 1445–1451 (2016).
Edgar, S. et al. Mechanistic insights into taxadiene epoxidation by taxadiene-5α-hydroxylase. ACS Chem. Biol. 11, 460–469 (2016).
Wheeler, A. L. et al. Taxol biosynthesis: differential transformations of taxadien-5 alpha-ol and its acetate ester by cytochrome P450 hydroxylases from Taxus suspension cells. Arch. Biochem. Biophys. 390, 265–278 (2001).
Biggs, B. W. et al. Overcoming heterologous protein interdependency to optimize P450-mediated Taxol precursor synthesis in Escherichia coli. Proc. Natl Acad. Sci. USA 113, 3209–3214 (2016).
Walker, K., Schoendorf, A. & Croteau, R. Molecular cloning of a taxa-4(20),11(12)-dien-5α-ol-O-acetyl transferase cDNA from Taxus and functional expression in Escherichia coli. Arch. Biochem. Biophys. 374, 371–380 (2000).
Schoendorf, A., Rithner, C. D., Williams, R. M. & Croteau, R. B. Molecular cloning of a cytochrome P450 taxane 10β-hydroxylase cDNA from Taxus and functional expression in yeast. Proc. Natl Acad. Sci. USA 98, 1501–1506 (2001).
Jennewein, S., Rithner, C. D., Williams, R. M. & Croteau, R. B. Taxol biosynthesis: taxane 13α-hydroxylase is a cytochrome P450-dependent monooxygenase. Proc. Natl Acad. Sci. USA 98, 13595–13600 (2001).
Walker, K. & Croteau, R. Molecular cloning of a 10-deacetylbaccatin III-10-O-acetyl transferase cDNA from Taxus and functional expression in Escherichia coli. Proc. Natl Acad. Sci. USA 97, 583–587 (2000).
Jonguitud Borrego, N. Production of novel taxane intermediates of anticancer drug Taxol using microbial consortia. [Doctoral dissertation, The University of Edinburgh] Edinburgh Research Archive. (2023).
Sainsbury, F., Thuenemann, E. C. & Lomonossoff, G. P. pEAQ: versatile expression vectors for easy and quick transient expression of heterologous proteins in plants. Plant Biotechnol. J. 7, 682–693 (2009).
De La Peña, R. & Sattely, E. S. Rerouting plant terpene biosynthesis enables momilactone pathway elucidation. Nat. Chem. Biol. 17, 205–212 (2021).
Reider Apel, A. et al. A Cas9-based toolkit to program gene expression in Saccharomyces cerevisiae. Nucleic Acids Res. 45, 496–508 (2017).
Rubenstein, S. M., Vazquez, A., Sanz-Cervera, J. F. & Williams, R. M. Synthesis of stable and radioisotopomers of Taxa-4(5),11(12)-diene, Taxa-4(20), 11(12)-diene and Taxa-4(20), 11(12)-dien-5-α-ol, early intermediates in Taxol® biosynthesis. J. Label. Comp. Radiopharm. 43, 481–491 (2000).
Chau, M., Walker, K., Long, R. & Croteau, R. Regioselectivity of taxoid-O-acetyltransferases: heterologous expression and characterization of a new taxadien-5α-ol-O-acetyltransferase. Arch. Biochem. Biophys. 430, 237–246 (2004).
Edgar, S., Li, F. S., Qiao, K., Weng, J. K. & Stephanopoulos, G. Engineering of taxadiene synthase for improved selectivity and yield of a key Taxol biosynthetic intermediate. ACS Synth. Biol. 6, 201–205 (2017).
Lau, W. & Sattely, E. S. Six enzymes from mayapple that complete the biosynthetic pathway to the etoposide aglycone. Science 349, 1224–1228 (2015).
Sarrion-Perdigones, A. et al. GoldenBraid 2.0: a comprehensive DNA assembly framework for plant synthetic biology. Plant Physiol. 162, 1618–1631 (2013).
Ahn, T., Guengerich, F. P. & Yun, C. H. Membrane insertion of cytochrome P450 1A2 promoted by anionic phospholipids. Biochemistry 37, 12860–12866 (1998).
Laursen, T. et al. Characterization of a dynamic metabolon producing the defense compound dhurrin in sorghum. Science 354, 890–893 (2016).
Menhard, B. & Zenk, M. H. Purification and characterization of acetyl coenzyme A: 10-hydroxytaxane O-acetyltransferase from cell suspension cultures of Taxus chinensis. Phytochemistry 50, 763–774 (1999).
Schultz, B. J., Kim, S. Y., Lau, W. & Sattely, E. S. Total biosynthesis for milligram-scale production of etoposide intermediates in a plant chassis. J. Am. Chem. Soc. 141, 19231–19235 (2019).
Luo, X. et al. Complete biosynthesis of cannabinoids and their unnatural analogues in yeast. Nature 567, 123–126 (2019).
Li, Z. et al. Engineering cytochrome P450 enzyme systems for biomedical and biotechnological applications. J. Biol. Chem. 295, 833–849 (2020).
Hausjell, J., Halbwirth, H. & Spadiut, O. Recombinant production of eukaryotic cytochrome P450s in microbial cell factories. Biosci. Rep. 38, BSR20171290 (2018).
Shang, Y. & Huang, S. Engineering plant cytochrome P450s for enhanced synthesis of natural products: past achievements and future perspectives. Plant Commun. 1, 100012 (2020).
McDaniel, R., Ebert-Khosla, S., Hopwood, D. A. & Khosla, C. Engineered biosynthesis of novel polyketides: actVII and actIV genes encode aromatase and cyclase enzymes, respectively. J. Am. Chem. Soc. 116, 10855–10859 (1994).
Paddon, C. J. et al. High-level semi-synthetic production of the potent antimalarial artemisinin. Nature 496, 528–532 (2013).
Michener, J. K., Nielsen, J. & Smolke, C. D. Identification and treatment of heme depletion attributed to overexpression of a lineage of evolved P450 monooxygenases. Proc. Natl Acad. Sci. USA 109, 19504–19509 (2012).
Geisler, K., Jensen, N. B., Yuen, M. M. S., Madilao, L. & Bohlmann, J. Modularity of conifer diterpene resin acid biosynthesis: P450 enzymes of different CYP720B clades use alternative substrates and converge on the same products. Plant Physiol. 171, 152–164 (2016).
Forman, V. et al. A gene cluster in Ginkgo biloba encodes unique multifunctional cytochrome P450s that initiate ginkgolide biosynthesis. Nat. Commun. 13, 5143 (2022).
Galanie, S., Thodey, K., Trenchard, I. J., Filsinger Interrante, M. & Smolke, C. D. Complete biosynthesis of opioids in yeast. Science 349, 1095–1100 (2015).
Huang, A. C. et al. A specialized metabolic network selectively modulates Arabidopsis root microbiota. Science 364, eaau6389 (2019).
De La Peña, R. et al. Complex scaffold remodeling in plant triterpene biosynthesis. Science 379, 361–368 (2023).
Pateraki, I. et al. Total biosynthesis of the cyclic AMP booster forskolin from Coleus forskohlii. Elife 6, e23001 (2017).
Lanier, E. R., Andersen, T. B. & Hamberger, B. Plant terpene specialized metabolism: complex networks or simple linear pathways? Plant J. 114, 1178–1201 (2023).
Kaspera, R. & Croteau, R. Cytochrome P450 oxygenases of Taxol biosynthesis. Phytochem. Rev. 5, 433–444 (2006).
Williams, D. C. et al. Heterologous expression and characterization of a ‘Pseudomature’ form of taxadiene synthase involved in paclitaxel (Taxol) biosynthesis and evaluation of a potential intermediate and inhibitors of the multistep diterpene cyclization reaction. Arch. Biochem. Biophys. 379, 137–146 (2000).
Acknowledgements
We would like to thank the Keasling lab (University of California, Berkeley) for providing the engineered yeast strains and, specifically, Michael Belcher and Graham Hudson (University of California, Berkeley) for discussion on fermentation protocol of the yeast strains. We also want to thank Stephen Lynch (Stanford University) for his helpful discussion on NMR structural elucidation. The author is thankful to all Sattely lab members for constructive feedback during the writing of this manuscript. This work is supported by NIH R01 AT010593 (E.S.S).
Author information
Authors and Affiliations
Contributions
J.C-T.L. and R.D.L.P. cloned the biosynthetic genes. R.D.L.P. developed the GCMS condition for taxane detection. J.C-T.L. and C.T. performed large-scale purification and structural characterization. J.C-T.L. constructed the plasmids for tuning expression level. J.C-T.L. and E.S.S. analyzed the data and wrote the manuscript. E.S.S. supervised the work.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Communications thanks Jakob Franke, Vincent Courdavault, and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. A peer review file is available.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Source data
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Liu, J.CT., De La Peña, R., Tocol, C. et al. Reconstitution of early paclitaxel biosynthetic network. Nat Commun 15, 1419 (2024). https://doi.org/10.1038/s41467-024-45574-8
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41467-024-45574-8
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.